NFSG Corp Sells 4,043 Shares of Synopsys, Inc. $SNPS

Key Points

• NFSG Corp cut its Synopsys stake by 85.5% during the third quarter, selling 4,043 shares and retaining 684 shares valued at approximately $297,000. Institutional investors collectively own 85.47% of the company.
• Analyst sentiment remains favorable, with Synopsys receiving a “Moderate Buy” consensus rating and an average price target of $571.78; several firms recently upgraded the stock or raised their targets.
• Synopsys shares fell 2.9% to $454.63, despite quarterly earnings and revenue exceeding expectations. The company also authorized a $1 billion share-repurchase program, while insiders have sold more than $51 million of stock over the past 90 days.

NFSG Corp lessened its stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 85.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 684 shares of the semiconductor company's stock after selling 4,043 shares during the quarter. NFSG Corp's holdings in Synopsys were worth $297,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Sankala Group LLC bought a new position in shares of Synopsys in the 4th quarter worth $25,000. Elevation Wealth Partners LLC lifted its stake in shares of Synopsys by 96.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company's stock worth $25,000 after purchasing an additional 27 shares during the last quarter. Osbon Capital Management LLC purchased a new stake in shares of Synopsys during the 2nd quarter worth $25,000. IMG Wealth Management Inc. bought a new stake in Synopsys during the second quarter valued at about $28,000. Finally, GK Wealth Management LLC bought a new stake in Synopsys during the third quarter valued at about $28,000. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have issued reports on SNPS. Robert W. Baird upgraded Synopsys from a "neutral" rating to an "outperform" rating and lifted their target price for the company from $558.00 to $560.00 in a research note on Thursday, August 27th. Morgan Stanley reduced their target price on shares of Synopsys from $525.00 to $500.00 and set an "equal weight" rating for the company in a report on Wednesday, August 19th. Barclays assumed coverage on shares of Synopsys in a research report on Friday, September 25th. They set an "overweight" rating for the company. UBS Group set a $570.00 price target on shares of Synopsys in a research report on Thursday, August 27th. Finally, Piper Sandler upgraded shares of Synopsys from a "neutral" rating to an "overweight" rating and raised their price target for the company from $450.00 to $550.00 in a report on Tuesday, June 23rd. One analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and four have issued a Hold rating to the company's stock. According to MarketBeat.com, Synopsys currently has an average rating of "Moderate Buy" and a consensus target price of $571.78.

Insiders Place Their Bets

In other news, insider Janet Lee sold 1,144 shares of the business's stock in a transaction dated Tuesday, October 6th. The stock was sold at an average price of $502.52, for a total transaction of $574,882.88. Following the sale, the insider owned 16,534 shares in the company, valued at approximately $8,308,665.68. The trade was a 6.47% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Sudhindra Kankanwadi sold 9,170 shares of the company's stock in a transaction dated Tuesday, October 6th. The shares were sold at an average price of $500.00, for a total transaction of $4,585,000.00. Following the transaction, the chief financial officer owned 22,717 shares in the company, valued at approximately $11,358,500. This trade represents a 28.76% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 117,163 shares of company stock valued at $51,366,457. 0.56% of the stock is owned by corporate insiders.

Synopsys Stock Down 2.9%

Shares of SNPS stock traded down $13.48 during trading hours on Friday, reaching $454.63. 2,515,910 shares of the company's stock were exchanged, compared to its average volume of 2,657,122. The stock's 50 day moving average is $427.56 and its 200-day moving average is $441.51. The company has a market cap of $87.13 billion, a price-to-earnings ratio of 80.32, a P/E/G ratio of 1.91 and a beta of 1.21. The company has a current ratio of 1.34, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. Synopsys, Inc. has a fifty-two week low of $362.55 and a fifty-two week high of $539.48.

Synopsys (NASDAQ:SNPS - Get Free Report) last posted its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, topping analysts' consensus estimates of $3.67 by $0.24. The firm had revenue of $2.48 billion during the quarter, compared to analysts' expectations of $2.44 billion. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. The business's quarterly revenue was up 42.4% on a year-over-year basis. During the same quarter last year, the firm earned $3.39 EPS. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Analysts predict that Synopsys, Inc. will post 10.97 earnings per share for the current fiscal year.

Synopsys announced that its board has authorized a stock repurchase program on Monday, October 5th that authorizes the company to buy back $1.00 billion in outstanding shares. This buyback authorization authorizes the semiconductor company to reacquire up to 1.1% of its stock through open market purchases. Share buyback programs are often a sign that the company's board of directors believes its stock is undervalued.

Synopsys Company Profile

Synopsys, Inc is a technology company that develops electronic design automation (EDA) software, semiconductor intellectual property (IP), and software tools used to design, verify, and manufacture advanced electronic systems. Its solutions support the development of semiconductors, systems-on-chip, and electronic products across the design cycle, from initial specification and architecture through testing and production.

The company's offerings include digital and custom integrated-circuit design tools, simulation and verification software, physical design and signoff products, and semiconductor IP such as processor cores, interface technologies, and foundational components.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.